We’re delighted to announce that Martin Gouldstone has joined Results International as a Partner, bringing a wealth of experience to the expanding healthcare team.
Martin joins Results with nearly 30 years’ experience in the Lifesciences sector. He joins the firm from BDO where he worked in Corporate Finance and led their Lifesciences sector approach. Before BDO he spent the previous 5 years at Quintiles where he ran the M&A process in Europe after building and leading the Product Strategy Consulting Practice in Europe. Martin has completed a large and varied number of deals in the sector ranging from early stage research collaborations and licensing deals in Biotech, to the $1bn end to end research collaboration between Quintiles and Merck Serono.
More recently he has completed a large number of M&A deals including the acquisitions of Kinapse by HG Capital in 2015, PhlexGlobal by Vitruvian, announced Dec 2016, Factory CRO in Holland by Kester Capital and the acquisition of Xendo, also in Holland, by Sovereign Capital both in 2016. In addition to deals in the services and healthcare IT sectors he has also completed the sale of a German Biotech, Birken, to Amryt Pharmaceuticals in late 2015.
Martin will be in New York from the 21st – 23rd March, should you wish to organise a meeting please email firstname.lastname@example.org